1 – 20 of 20
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity
(
- Contribution to journal › Article
-
Mark
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry
(
- Contribution to journal › Article
- 2019
-
Mark
ALK positively regulates MYCN activity through repression of HBP1 expression
(
- Contribution to journal › Article
- 2015
-
Mark
Individual patient risk stratification of high-risk neuroblastomas using a two-gene score suited for clinical use.
(
- Contribution to journal › Article
-
Mark
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
(
- Contribution to journal › Article
-
Mark
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis
(
- Contribution to journal › Article
- 2014
-
Mark
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
(
- Contribution to journal › Article
- 2013
-
Mark
Intratumour diversity of chromosome copy numbers in neuroblastoma mediated by on-going chromosome loss from a polyploid state.
(
- Contribution to journal › Article
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
-
Mark
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
(
- Contribution to journal › Article
- 2012
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
(
- Contribution to journal › Article
-
Mark
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
(
- Contribution to journal › Article
-
Mark
Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma
(
- Contribution to journal › Article
-
Mark
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
(
- Contribution to journal › Article
- 2009
-
Mark
The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo
(
- Contribution to journal › Article
-
Mark
Lysine-Specific Demethylase 1 Is Strongly Expressed in Poorly Differentiated Neuroblastoma: Implications for Therapy.
(
- Contribution to journal › Article
- 2008
-
Mark
The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is'-down-regulated by MYCN
(
- Contribution to journal › Article
- 2007
-
Mark
Direct regulation of the minichromosome maintenance complex by MYCN in neuroblastoma
(
- Contribution to journal › Article